Oxford BioMedica PLC (OXBDF)
3.79
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Oxford BioMedica Price to Book Value: 4.020 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 4.020 |
| May 03, 2024 | 4.020 |
| May 02, 2024 | 4.020 |
| May 01, 2024 | 3.087 |
| April 30, 2024 | 3.087 |
| April 29, 2024 | 3.087 |
| April 26, 2024 | 3.087 |
| April 25, 2024 | 2.991 |
| April 24, 2024 | 2.885 |
| April 23, 2024 | 2.885 |
| April 22, 2024 | 2.779 |
| April 19, 2024 | 2.774 |
| April 18, 2024 | 2.774 |
| April 17, 2024 | 2.774 |
| April 16, 2024 | 2.774 |
| April 15, 2024 | 2.774 |
| April 12, 2024 | 2.774 |
| April 11, 2024 | 2.774 |
| April 10, 2024 | 2.784 |
| April 09, 2024 | 2.784 |
| April 08, 2024 | 2.784 |
| April 05, 2024 | 2.784 |
| April 04, 2024 | 2.588 |
| April 03, 2024 | 2.588 |
| April 02, 2024 | 2.578 |
| Date | Value |
|---|---|
| April 01, 2024 | 2.578 |
| March 28, 2024 | 2.576 |
| March 27, 2024 | 2.576 |
| March 26, 2024 | 2.576 |
| March 25, 2024 | 2.629 |
| March 22, 2024 | 2.608 |
| March 21, 2024 | 2.608 |
| March 20, 2024 | 2.545 |
| March 19, 2024 | 2.545 |
| March 18, 2024 | 2.545 |
| March 15, 2024 | 2.587 |
| March 14, 2024 | 2.723 |
| March 13, 2024 | 2.723 |
| March 12, 2024 | 2.884 |
| March 11, 2024 | 2.884 |
| March 08, 2024 | 2.884 |
| March 07, 2024 | 2.884 |
| March 06, 2024 | 2.631 |
| March 05, 2024 | 2.651 |
| March 04, 2024 | 2.301 |
| March 01, 2024 | 2.311 |
| February 29, 2024 | 2.311 |
| February 28, 2024 | 2.311 |
| February 27, 2024 | 2.311 |
| February 26, 2024 | 2.311 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9721
Minimum
Dec 04 2023
16.89
Maximum
Jun 10 2019
5.111
Average
5.283
Median
Sep 12 2019
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 7.059 |
| Biodexa Pharmaceuticals Plc | 0.8168 |
| Verona Pharma PLC | 4.847 |
| NuCana PLC | 0.4326 |
| Autolus Therapeutics PLC | 9.709 |
Price to Book Value Related Metrics
| PS Ratio | 3.278 |
| Price | 3.79 |
| Earnings Yield | -53.58% |
| Market Cap | 379.00M |